Skip to main content

Advertisement

SpringerLink
Log in

Topical beta-blocker treatment for migraine

  • Case Report
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Beta-blockers are a well-known prophylactic treatment for migraine; however, treatment by the ocular route has not been widely considered. This case illustrates the resolution of a visual field defect associated with migraine and improvement of symptoms possibly due to administration of a topical beta-blocker. This novel method of treatment especially when visual field defects are present may have a place in the management of migraine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Comoglu S, Yarangumeli A, Gurbuz Koz O, Halil Elhan A, Kural G (2003) Glaucomatous visual field defects in patients with migraine. J Neurol 250(2):201–206

    Article  PubMed  Google Scholar 

  2. McKendrick AM, Vingrys AJ, Badcock DR, Heywood JT (2000) Visual field losses in subjects with migraine headaches. Invest Ophthalmol Vis Sci 41(5):1239–1247

    PubMed  CAS  Google Scholar 

  3. Connor RCR (1962) Complicated migraine: a study of permanent neurological and visual defects caused by migraine. Lancet 2:1072–1075

    Article  PubMed  CAS  Google Scholar 

  4. Sheddan AH, Laurence J, Barrish A, Olah TV (2001) Plasma timolol concentrations of timolol maleate: timolol gel-forming solution (TIMOPTIC-XE) once daily versus timolol maleate ophthalmic solution twice daily. Doc Ophthalmol 103(1):73–79

    Article  Google Scholar 

  5. Bhagey J, James B (2004) Topical timolol prevented migraine attacks. Eye 18:751

    Article  PubMed  CAS  Google Scholar 

  6. Ishikawa H, Yoshihara M, Mizuki K, Kashima Y (2000) A pediatric case of ophthalmoplegic migraine with recurrent oculomotor nerve palsy. Jpn J Ophthalmol 44(5):576

    Article  PubMed  Google Scholar 

  7. Gross RL, Hensley SH, Gao F, Wu SM (1999) Retinal ganglion cell dysfunction induced by hypoxia and glutamate: potential neuroprotective effects of beta-blockers. Surv Ophthalmol 43(1):S162–S170

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The author has no propriety interest in any of the product mentioned in this case report.

Author information

Authors and Affiliations

  1. Eye Unit, Stoke Mandeville Hospital, Aylesbury, Buckinghamshire, HP21 8AL, UK

    Patrick J. T. Chiam

Authors
  1. Patrick J. T. Chiam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrick J. T. Chiam.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chiam, P.J.T. Topical beta-blocker treatment for migraine. Int Ophthalmol 32, 85–88 (2012). https://doi.org/10.1007/s10792-012-9516-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-012-9516-6

Keywords

Search

Navigation